Cell and Gene Therapy 2018 Conference

From manufacturing to patient access: discover the world of advanced therapy medicinal products

October 10-11, 2018 - London, United Kingdom

Conference Proceedings

Standard Price

US$ 623.75

User Details



We introduce our inaugural conference; Cell and Gene Therapy, which takes place between the 9th and 11th October 2018.

Cell and gene therapeutics have revolutionised modern medicine and mark a new generation in biomedical and agricultural sciences. The latest developments in cell and gene therapies and specifically in gene editing technologies present unlimited research opportunities ranging from novel therapeutic tools to a potential revolution in the field of drug discovery.

This year event will be led by scientists and clinicians researching, developing and testing new treatments for genetically inherited and acquired diseases using gene delivery technology, stem cell manipulation and DNA repair techniques. The conference will cover all aspects of the subject, including biomedical science principles, molecular basis of disease, current and developing technologies and clinical applications.

Join our expert speaker panel at the Cell and Gene Therapy conference to ensure you do not miss out on the latest developments! Presenting new technologies, specific case studies, updates on GMP, MHRA regulatory guidelines, quality control and therapeutic applications of stem cells, pre-clinical and clinical trial design, advanced cell engineering technologies, commercialisation of ATMPs, global pricing, ethical overviews and many more.


Benefits of Attending

Cell and Gene Therapy will be inviting speakers from global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions.

Expect over 16 presentations and case studies focused on the key aspects of drug discovery, safety and toxicology assessments, bioprocessing, regulatory frameworks and patient access in the field of cell and gene therapy.

Join our expert speaker panel this October to ensure you do not miss out on the latest developments!

Presenting sessions on:
  • Cell Therapy Research Manufacturing Innovation
  • Global Medical Affairs
  • Regulatory Updates
  • GMP and Quality Control
  • Cell and Tissue Therapies (CART therapies, stem cells, cord blood, preclinical and clinical developments)
  • Regenerative Medicine
  • Advanced Therapy Production
  • Gene Therapy Development
  • Clinical Platform Development
  • Manufacturing and RD of Cell and Gene Therapies


Who should attend

Speakers and delegates will include CEOs, CSOs, CMOs, VPs, Senior and Principle Scientists Researchers, Scientists, Medical Doctors and Professionals in the fields of:
  • Drug Discovery & Development
  • Personalized , Translational, Stratified, Regenerative and Experimental Medicine
  • Cell / Molecular Biology
  • Cell / Gene Therapy
  • Rare & ultra-rare diseases
  • Genetic Diseases
  • Ophthalmology
  • Cancer / Oncology
  • Market Access
  • Pricing & Reimbursement
  • Patient Advocacy
  • Regulatory & Medical Affairs
  • Commercial Development
  • Bioinformatics
  • Big Data
  • Digital Health


Plus Two Interactive Half-Day Pre-Conference Workshops | Tuesday 9th October

Workshop A: Practicalities in the development of stem cell therapies
Workshop leader: Paul Stroemer, Director, Advanced Therapies consultancy
08.30 - 12.30

Workshop B: Strategic competitive intelligence in the cell and gene therapy space
Workshop leaders: Timos Papagatsias, CEO, LucidQuest
13.30 - 17.00

Speakers

  • Diego Ardigo, R&D Rare Disease Unit Head, Chiesi Farmaceutici S.p.A.
  • EJ Brandreth, Vice President, Inovio Pharmaceuticals
  • Emanuela Cuomo, Associate Director, AstraZeneca
  • Fabio D'Agostino, Partner, Alira Health
  • Giuseppe Ronzitti, Cell and Gene Therapy Specialist, Genethon
  • Ian McKay, Innovation Lead, Advanced Therapies, Innovate Uk
  • Ioannis Papantoniou, ATMP Bioprocessing Coordinator, KU Leuven
  • Janet Glassford, Quality Assessor , Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Julie Kerby, Head of Process Industrialisation , Cell and Gene Therapy Catapult
  • Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences Inc.
  • Lior Raviv, Vice President of Development, Pluristem
  • Mehdi Gasmi, Chief Science and Technology Officer, Adverum Biotechnology
  • Pamela Tranter, Head of Translational Research Group, UCL
  • Paul Lloyd-Evans, Operations Manager, NHSBT
  • Peggy Sotiropoulou, R&D Manager, Celyad
  • Shailesh Gupta, Senior Scientist, AstraZeneca PLC
  • Steven Kanner, Chief Scientific Officer, Caribou Biosciences, Inc.
  • Yen Choo, Founder and Executive Chairman, Plasticell

Please fill in your name and email to receive the conference agenda of this event.



Venue

Copthorne Tara Hotel
Scarsdale Pl, Kensington, W8 5SY
London, UK

Venue

Copthorne Tara Hotel
Scarsdale Place, Kensington
London, United Kingdom
Cell and Gene Therapy
Event details
Organizer :SAE Media Group
Event type :Conference
Attendance :Physical Event
Reference :ASDE-18854